THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 33 filers reported holding THERAVANCE INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,169,000 | +1.3% | 4,748,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $5,101,000 | -1.4% | 4,748,000 | -6.7% | 0.01% | 0.0% |
| Q2 2021 | $5,174,000 | +1.6% | 5,091,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $5,094,000 | +35.6% | 5,091,000 | +34.8% | 0.01% | +50.0% |
| Q4 2020 | $3,758,000 | +3.9% | 3,778,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,616,000 | +1.5% | 3,778,000 | +4.7% | 0.00% | -20.0% |
| Q2 2020 | $3,563,000 | -23.7% | 3,610,000 | -28.1% | 0.01% | -28.6% |
| Q1 2020 | $4,670,000 | -7.2% | 5,024,000 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $5,035,000 | +6.8% | 5,024,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $4,716,000 | -10.5% | 5,024,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $5,269,000 | +29.7% | 5,024,000 | +25.5% | 0.01% | +40.0% |
| Q1 2019 | $4,062,000 | -16.2% | 4,004,000 | -10.8% | 0.01% | -28.6% |
| Q4 2018 | $4,849,000 | – | 4,487,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 78,022,000 | $72,798,000 | 1.29% |
| Opti Capital Management, LP | 5,200 | $4,850,000 | 0.99% |
| Shaolin Capital Management LLC | 7,500,000 | $6,983,000 | 0.97% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 36,159,000 | $33,613,000 | 0.73% |
| Castle Creek Arbitrage, LLC | 3,583,000 | $3,338,000 | 0.54% |
| AQR Arbitrage LLC | 16,543,000 | $15,441,000 | 0.52% |
| DeepCurrents Investment Group LLC | 7,500,000 | $6,997,000 | 0.34% |
| CSS LLC/IL | 3,484,000 | $3,257,000 | 0.26% |
| SSI INVESTMENT MANAGEMENT LLC | 2,800,000 | $2,604,000 | 0.23% |
| Polar Asset Management Partners Inc. | 7,000,000 | $6,521,000 | 0.13% |